Choosing the Right CRO: Fully Loaded Freight Train or SUV
Phase I-IV clinical trials are complex. Project managers and their teams have to keep close watch on activities ranging from patient recruitment, enrollment, and retention to database lock while adhering to budget and timeline requirements. And each step of the way, nothing can compromise patient safety. Read more
Can You Reach Your CRO’s CEO?
When it comes to the relationships between biopharmaceutical and medical device companies (also known as Sponsors) and clinical research organizations (CROs), executive participation is essential and shouldn’t be restricted to options of the last resort. Read more
Five Ways to Ensure Virtual Team Effectiveness
Biopharmaceutical and medical device companies have long understood the importance of conducting Phase I-IV clinical trials on a global basis. Read more
Cost-Effective Phase I-IV Global Trials Through Virtual Project Management
As biopharmaceutical and medical device companies continue pushing global boundaries to conduct their Phase I-IV studies, clinical research organizations (CROs) offer increasingly sophisticated, and efficient, virtual project teams. Read more
Clinical Trial Complexity Mitigated by Therapeutic Expertise
Therapeutic expertise is one of the most effective ways clinical research organizations (CROs) can help biopharmaceutical and medical device companies contain clinical trial costs. Read more
Five Point Checklist for Conference Selection
In the clinical research industry, large conferences such as Partnerships in Clinical Trials and the Drug Information Association (DIA) Annual Meeting are highly anticipated because of their relevant content, excellent professional sessions, and high profile speakers. Read more
Leveraging Relevant Conferences to Build Market Share
Professional conferences are important to most industries, including the clinical research and development industry. For me, conferences are professionally rewarding and have also proven to be vital to strengthening market share.
Celebrate National Wear Red Day
Join ParaBioPlus as we celebrate National Wear Red Day this Friday, Feb 5.
Economics 2010
The risks and rewards of clinical research and development are high, and as a result, pharmaceutical, biotechnology, and medical device companies are compelled to fully understand the implications of their decisions.
ParaBioPlus is Your Research Community
ParaBioPlus was launched to fill a growing need for an online community focused on biopharmaceutical and clinical research organization (CRO) issues relevant to clinical research professionals.